Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

NCT04758650 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Solid Malignancy Located in the Head and Neck
Cancer
Carotid Stenosis
Atherosclerosis of Artery
Hodgkin Lymphoma, Adult
Non Hodgkin Lymphoma
HLH
Cardiac Sarcoidosis
Sarcoidosis

Interventions

DRUG: 68GaNOTA-Anti-MMR-VHH2

Sponsor

Universitair Ziekenhuis Brussel